NeuroPace, Inc. (NPCE) vs Viemed Healthcare, Inc. (VMD)
- NeuroPace, Inc. NPCE 12.24 −4.23%
- Viemed Healthcare, Inc. VMD 9.48 −2.77%
NeuroPace, Inc. and Viemed Healthcare, Inc. are both Medical Devices companies. NeuroPace, Inc. is the larger, with a market value of $438.7M against $371.4M — 1.2× the size. NeuroPace, Inc. has negative trailing earnings, so its P/E is not meaningful; Viemed Healthcare, Inc. trades at 24.9×. Viemed Healthcare, Inc. grew revenue faster over the last twelve months: 25.2% against 21.7%. Viemed Healthcare, Inc. has the higher net margin (4.81% vs −18.6%) and the higher return on invested capital (10.7% vs −44.6%). Across the 19 metrics below, Viemed Healthcare, Inc. leads on 15 and NeuroPace, Inc. on 4.
Valuation
Profitability
| Metric | NPCE | VMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 78.38% | 57.47% | 56.01% |
| Operating margin | (13.33%) | 8.05% | (15.03%) |
| Net margin | (18.58%) | 4.81% | (20.40%) |
| Free cash flow margin | (11.29%) | 11.42% | (7.24%) |
| Return on equity | (122.05%) | 10.08% | (15.32%) |
| Return on assets | (18.82%) | 7.46% | (19.72%) |
| Return on invested capital | (44.64%) | 10.66% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack